Profile data is unavailable for this security.
About the company
The Hydration Pharmaceuticals Company Limited is an Australia-based hydration solutions company. The Company is focused on the sale and distribution of Hydralyte, which includes a product range of electrolyte-rich tablets, liquids, and powders. The Company markets and sells a range of liquid, tablet, and powder healthy hydration solutions products in the North American markets of Canada and the United States, under the Hydralyte brand. The Company operates as a wholesale supplier and online retailer of Hydralyte products in North America. The Company has a sales footprint in various markets, including the United States, Canada, China, and the United Kingdom. Its subsidiaries include Hydration Pharmaceuticals Trust, Hydration Pharmaceuticals Canada, Hydralyte LLC, and others.
- Revenue in AUD (TTM)15.04m
- Net income in AUD-12.13m
- Incorporated2017
- Employees--
- LocationHydration Pharmaceuticals Co LtdLevel 2,, 6 Palmer Parade,, CremorneMELBOURNE 3121AustraliaAUS
- Websitehttps://hydralyte.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nutritional Growth Solutions Ltd | 4.47m | -4.33m | 1.00m | -- | -- | -- | -- | 0.2249 | -0.0239 | -0.0239 | 0.0232 | -0.0011 | 1.51 | 2.19 | 61.53 | -- | -145.93 | -- | -303.09 | -- | 28.22 | 42.47 | -96.95 | -152.30 | 0.1888 | -- | 1.96 | -- | 1.26 | 41.61 | 31.91 | -- | -- | -- |
| Wellfully Ltd | 1.31m | -1.34m | 1.48m | 36.00 | -- | -- | -- | 1.13 | -0.003 | -0.003 | 0.0034 | -0.0034 | 0.377 | 0.3166 | 1.57 | -- | -38.36 | -175.88 | -- | -441.84 | 48.61 | -- | -101.74 | -266.08 | 0.2159 | -- | -- | -- | -42.78 | -5.87 | 12.98 | -- | 21.75 | -- |
| Tryptamine Therapeutics Ltd | 1.21m | -4.32m | 1.93m | -- | -- | 1.78 | -- | 1.60 | -0.0162 | -0.0162 | 0.0037 | 0.0062 | 0.2368 | -- | -- | -- | -84.69 | -66.34 | -120.26 | -79.70 | -- | -- | -357.70 | -228.11 | -- | -21.62 | 0.00 | -- | -18.97 | 138.73 | 29.29 | -- | 68.45 | -- |
| BPH Global Ltd | 0.00 | -2.56m | 1.95m | 31.00 | -- | -- | -- | -- | -0.002 | -0.0025 | 0.00 | -0.0002 | 0.00 | 0.00 | -- | -- | -177.78 | -68.17 | -784.87 | -128.99 | -- | 15.29 | -- | -131.89 | 0.5587 | -4.92 | -- | -- | -99.93 | -74.08 | 19.71 | -- | 1.34 | -- |
| Hexima Ltd | 193.85k | -753.18k | 2.00m | -- | -- | 0.7877 | -- | 10.34 | -0.0045 | -0.0045 | 0.0012 | 0.0152 | 0.0558 | -- | 0.2705 | -- | -21.67 | -72.85 | -26.54 | -193.37 | -- | -- | -388.54 | -213.09 | -- | -- | 0.00 | -- | 271.52 | -19.43 | 80.85 | -- | -- | -- |
| Melodiol Global Health Ltd | 19.60m | -35.52m | 2.14m | -- | -- | -- | -- | 0.1092 | -0.2548 | -0.3762 | 0.1578 | -0.0172 | 0.6874 | 4.35 | 10.62 | -- | -124.57 | -102.92 | -387.77 | -152.32 | 15.38 | -- | -181.22 | -348.92 | 0.1594 | -6.71 | 1.73 | -- | 210.13 | 94.60 | -62.47 | -- | -46.82 | -- |
| Holista Colltech Limited | 5.95m | -4.81m | 2.79m | 3.00 | -- | -- | -- | 0.4686 | -0.0172 | -0.0172 | 0.0213 | -0.0071 | 1.35 | 2.49 | 4.70 | -- | -111.49 | -42.59 | -347.69 | -63.58 | 56.66 | 56.37 | -82.68 | -39.27 | 0.2845 | -- | -- | -- | -27.82 | -5.65 | -230.77 | -- | -37.12 | -- |
| Hydration Pharmaceuticals Co Ltd | 15.04m | -12.13m | 3.96m | -- | -- | -- | -- | 0.2636 | -0.0622 | -0.0622 | 0.0771 | -0.002 | 1.18 | 1.61 | 6.60 | -- | -94.86 | -79.98 | -143.75 | -111.57 | 53.70 | 48.73 | -80.69 | -99.53 | 1.37 | -21.48 | 1.10 | -- | 10.34 | 19.27 | 23.61 | -- | -- | -- |
| Bod Science Ltd | 3.32m | -7.95m | 4.26m | -- | -- | -- | -- | 1.28 | -0.0557 | -0.0557 | 0.0235 | -0.0046 | 0.7533 | 2.42 | 8.05 | -- | -180.40 | -94.62 | -465.66 | -145.77 | 69.23 | 47.08 | -239.47 | -129.48 | 0.8319 | -- | 3.71 | -- | -34.70 | 23.20 | -47.10 | -- | 8.23 | -- |
| Cambium Bio Ltd | -28.22k | -366.01k | 5.36m | -- | -- | -- | -- | -- | -0.0012 | -0.0012 | -0.00009 | -0.0036 | -0.039 | -- | -- | -- | -50.58 | -49.44 | -- | -292.47 | -- | -- | -- | -118.34 | -- | -- | -- | -- | -- | -- | 60.86 | -- | -- | -- |
| Zelira Therapeutics Ltd | 1.62m | -36.43m | 5.56m | 8.00 | -- | -- | -- | 3.43 | -3.23 | -3.23 | 0.148 | -0.2063 | 0.0848 | 0.185 | 3.55 | -- | -193.14 | -27.71 | -243.04 | -28.81 | 82.28 | -- | -2,278.17 | -508.48 | 0.1488 | -22.80 | -- | -- | -80.95 | -0.3635 | 53.35 | -- | -- | -- |
| Invex Therapeutics Ltd | 837.95k | -6.01m | 5.71m | -- | -- | 1.08 | -- | 6.82 | -0.08 | -0.08 | 0.0112 | 0.0705 | 0.0521 | -- | 2.79 | -- | -37.38 | -- | -40.06 | -- | -- | -- | -717.76 | -- | -- | -- | 0.00 | -- | 379.22 | -- | -96.04 | -- | -- | -- |
Data as of May 14 2024. Currency figures normalised to Hydration Pharmaceuticals Co Ltd's reporting currency: Australian Dollar AUD
34.55%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| PURE Asset Management Pty Ltd.as of 10 May 2024 | 60.95m | 22.99% |
| Regal Funds Management Pty Ltd.as of 20 Sep 2023 | 27.70m | 10.45% |
| Gowing Bros. Ltd. (Investment Management)as of 03 Mar 2023 | 2.96m | 1.12% |
Data from 31 Jul 2020 - 10 May 2024Source: FactSet Research Systems Inc.
